Filing Details

Accession Number:
0000716054-10-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-29 12:53:05
Reporting Period:
2010-12-23
Filing Date:
2010-12-29
Accepted Time:
2010-12-29 12:53:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
716054 Cypress Bioscience Inc CYPB Biological Products, (No Disgnostic Substances) (2836) 222389839
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055666 D Jay Kranzler 4350 Executive Drive Suite 214
San Diego CA 92121
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-23 152,464 $3.25 249,206 No 4 M Indirect By Trust
Common Stock Disposition 2010-12-23 152,464 $6.45 96,742 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By Trust
No 4 S Indirect By Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Disposition 2010-12-23 152,464 $0.00 152,464 $3.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-04-29 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 625 Direct
Common Stock 398,692 Indirect By 401(k) Plan
Footnotes
  1. The weighted average sale price for the transaction reported was $6.4501, the range of prices were between $6.45 and $6.455. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
  2. The shares subject to the option are fully vested
  3. Between January 1, 2010 and December 14, 2010, 196,440 shares of Common Stock were transfered into the Cypress Bioscience, Inc. 401(k) plan, of which the Reporting Person is the trustee and has voting power over such shares.